Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thales Papagiannakopoulos

Showing results (1-10 of 81) with videos related to

Pageof 9
Sort By:
Cancer Letters|March 23, 2016
Application of CRISPR-mediated genome engineering in cancer researchVolkan I Sayin, Thales Papagiannakopoulos
Cell Stem Cell|May 12, 2009
MicroRNA-124: micromanager of neurogenesisThales Papagiannakopoulos, Kenneth S Kosik
Molecular Cell|December 4, 2020
The Center Cannot Hold: NRF2 Battles Ferroptosis in the 3rd DimensionWarren L Wu, Thales Papagiannakopoulos
BMC Medicine|June 26, 2008
MicroRNAs: regulators of oncogenesis and stemnessThales Papagiannakopoulos, Kenneth S Kosik
Trends in Cell Biology|May 26, 2021
Hunger brings down the tumor fortAnastasia-Maria Zavitsanou, Thales Papagiannakopoulos
Nature Metabolism|April 7, 2026
Drowning in cysteineAlec J Vaughan, Thales Papagiannakopoulos
Biophysical Reviews|March 1, 2020
Metabolic features of cancer cells in NRF2 addiction statusKeito Okazaki, Thales Papagiannakopoulos, Hozumi Motohashi
Genes & Development|October 3, 2024
Bridging brain and body in cancerMichael Cross, Andrew Dillin, Thales Papagiannakopoulos
Trends in Cancer|November 4, 2023
Reductive stress in cancer: coming out of the shadowsMaolin Ge, Thales Papagiannakopoulos, Liron Bar-Peled
Cancer Research|October 3, 2008
MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cellsThales Papagiannakopoulos, Alice Shapiro, Kenneth S Kosik
Pageof 9

Showing results (1-10 of 81) with videos related to

Sort By:
Pageof 9
Cancer Letters|March 23, 2016
Application of CRISPR-mediated genome engineering in cancer researchVolkan I Sayin, Thales Papagiannakopoulos
Cell Stem Cell|May 12, 2009
MicroRNA-124: micromanager of neurogenesisThales Papagiannakopoulos, Kenneth S Kosik
Molecular Cell|December 4, 2020
The Center Cannot Hold: NRF2 Battles Ferroptosis in the 3rd DimensionWarren L Wu, Thales Papagiannakopoulos
BMC Medicine|June 26, 2008
MicroRNAs: regulators of oncogenesis and stemnessThales Papagiannakopoulos, Kenneth S Kosik
Trends in Cell Biology|May 26, 2021
Hunger brings down the tumor fortAnastasia-Maria Zavitsanou, Thales Papagiannakopoulos
Nature Metabolism|April 7, 2026
Drowning in cysteineAlec J Vaughan, Thales Papagiannakopoulos
Biophysical Reviews|March 1, 2020
Metabolic features of cancer cells in NRF2 addiction statusKeito Okazaki, Thales Papagiannakopoulos, Hozumi Motohashi
Genes & Development|October 3, 2024
Bridging brain and body in cancerMichael Cross, Andrew Dillin, Thales Papagiannakopoulos
Trends in Cancer|November 4, 2023
Reductive stress in cancer: coming out of the shadowsMaolin Ge, Thales Papagiannakopoulos, Liron Bar-Peled
Cancer Research|October 3, 2008
MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cellsThales Papagiannakopoulos, Alice Shapiro, Kenneth S Kosik
Pageof 9